Three versus six weeks of post-amputation antibiotic therapy in diabetic forefoot osteomyelitis with positive culture for residual infected bone - 16/10/24
Highlights |
• | We compared 6 vs 3 weeks of post-amputation antibiotic therapy in diabetic patients with forefoot osteomyelitis and residual bone infection. |
• | During the six-month follow-up, the overall cure rate was 95 % and similar in both groups. |
• | Three weeks of post-amputation antibiotic therapy seems effective. |
Abstract |
Objectives |
In 2021 in our university hospital, it was decided in a multidisciplinary consultation meeting on osteoarticular infection in patients with diabetic foot to reduce the duration of post-amputation antibiotic therapy from six to three weeks in patients with diabetic forefoot osteomyelitis and residual bone infection. This study aimed to compare clinical outcomes in this group of patients, before vs after the change in practice introduced in 2021.
Methods |
In this before-after study, we included all cases reported between January 2016 and August 2023 in the University Hospital of Reims.
Results |
We included 113 patients; between 2016 and 2020, 56 (49.5 %) received six weeks of post-amputation antibiotic therapy, and between 2021 and 2023, 57 (50.5 %) received three weeks of therapy. Over six months of follow-up, overall cure rate was 95 %. Treatment failure did not differ between groups.
Conclusion |
Three weeks of post-amputation antibiotic therapy in diabetic patients with forefoot osteomyelitis and residual bone infection is effective.
Le texte complet de cet article est disponible en PDF.Keywords : Diabetic foot osteomyelitis, Diabetic foot infection, Surgical amputation, Post-amputation antibiotic therapy, Residual infected bone
Plan
Vol 54 - N° 7
Article 104975- octobre 2024 Retour au numéro
Article précédent
- New guidelines reduce the risk of hospitalization for adult patients with uncomplicated Plasmodium falciparum malaria: An observational, multicenter, retrospective French study
- Sally Oceane Minka, Gilles Cottrell, Michel Cot, Fadi Hillary Minka, Marc Thellier, Christophe Choquet, Sandrine Houze
- A case series of intermittent nucleoside analogue-based (NA) regimen to maintain HBV virological suppression in coinfected HBV/HIV patients with suppressed viremia
- S. Seang, P. Detruchis, E. Todesco, M-A. Valantin, L. Schneider, R. Palich, G. Peytavin, V. Pourcher, A-G. Marcelin, C. Katlama
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?